Jasper Therapeutics, Inc. · NASDAQ:JSPR
Carlyle Group Inc. reported a 3.80% stake in Jasper Therapeutics, Inc. (Schedule 13D/A)
Event Feb 18, 2026 · Filed Feb 18, 2026
Carlyle Group Inc. reported a 3.80% stake in Jasper Therapeutics, Inc., 1,088,310 shares, with active intent on Feb 18, 2026. Filed Feb 18, 2026 (Schedule 13D/A).
- Stake
- 3.80%
- Shares
- 1,088,310
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Carlyle Group Inc. | 3.80% | 1,088,310 |
| Carlyle Holdings I GP Inc. | 3.80% | 1,088,310 |
| Carlyle Holdings I GP Sub L.L.C. | 3.80% | 1,088,310 |
| Carlyle Holdings I L.P. | 3.80% | 1,088,310 |
| CG Subsidiary Holdings L.L.C. | 3.80% | 1,088,310 |
| TC Group, L.L.C. | 3.80% | 1,088,310 |
| Carlyle Investment Management L.L.C. | 3.80% | 1,088,310 |
| Carlyle Genesis UK LLC | 3.80% | 1,088,310 |
| Abingworth LLP | 3.80% | 1,088,310 |
| Abingworth Bioventures VII LP | 3.80% | 1,088,310 |
Source
Related
- Jasper Therapeutics, Inc.
- Carlyle Group Inc.
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Jul 20, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026